206 results on '"Vriesendorp, H M"'
Search Results
2. Survival after Total-Body Irradiation. I. Effects of Partial Small Bowel Shielding
3. Susceptibility to Total Body Irradiation
4. Role of Total Body Irradiation in Conditioning for Bone Marrow Transplantation
5. Minor Histocompatibility Systems in Dogs
6. Bone Marrow Transplantation
7. The Major Histocompatibility System of the Dog
8. Value of the mixed lymphocyte reaction in dogs as a genetic assay
9. Role of Total Body Irradiation in Conditioning for Bone Marrow Transplantation
10. Survival After Total Body Irradiation: Effects of Irradiation of Exteriorized Small Intestine
11. The next (third) dimension to dosing of anticancer agents.
12. BOOK REVIEW
13. Survival of patients with resistant Hodgkin's disease after polyclonal yttrium 90-labeled antiferritin treatment.
14. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
15. LIVER TOXICITY OF COMBINED EXTERNAL BEAM IRRADIATION AND RADIOLABELED IMMUNOGLOBULIN THERAPY (RIT)
16. BREMSSTRAHLUNG IMAGING OF PATIENTS WITH HODGKINʼS DISEASE AFTER YTTRIUM-90 LABELED ANTIFERRITIN ADMINISTRATION
17. BIODISTRIBUTION STUDIES WITH HUMAN MONOCLONAL IgM ANTIBODY REACTIVE WITH OVARIAN CARCINOMA
18. TREATMENT OF REFRACTORY END STAGE HODGKINʼS DISEASE WITH YTTRIUM-90 POLYCLONAL ANTIFERRITIN ANTIBODIES
19. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
20. SCIENTIFIC POSTERS
21. 111 In ANTIFERRITIN MURINE POLYCLONAL ANTIBODY IN THE PRETREATMENT EVALUATION OF PATIENTS WITH RECURRENT HODGKINʼS DISEASE
22. Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease.
23. Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.
24. Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.
25. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
26. THE EFFECT OF DONOR BLOOD ON RENAL ALLOGRAFT SURVIVAL IN DL-A TISSUE TYPED BEAGLE LITTERMATES.
27. Prediction of normal tissue damage induced by cancer chemotherapy.
28. Immunogenetic markers in canine paternity cases.
29. Interstitial pneumonitis after allogeneic bone marrow transplantation. Nine-year experience at a single institution.
30. Identification of Four MLC-Specificities in the Dog.
31. ENGRAFTMENT OF STEM-CELL-ENRICHED BONE MARROW FRACTIONS IN MHC-IDENTICAL DOGS AFTER FRACTIONATED TOTAL-BODY IRRADIATION1.
32. JOINT REPORT OF THE THIRD INTERNATIONAL WORKSHOP ON CANINE IMMUNOGENETICS.
33. GENETICS OF KIDNEY ALLOGRAFT SURVIVAL IN DOGS II. RELEVANCE OF MINOR HISTOCOMPATIBILITY SYSTEMS IN RECIPIENTS WITHOUT IMMUNOSUPPRESSIVE THERAPY1.
34. GENETICS OF KIDNEY ALLOGRAFT SURVIVAL IN DOGS I. RELEVANCE OF SUBREGIONS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN RECIPIENTS WITHOUT IMMUNOSUPPRESSIVE THERAPY.
35. PROLONGATION OF RENAL ALLOGRAFT SURVIVAL IN DLA TISSUE-TYPED BEAGLES AFTER THIRD-PARTY BLOOD TRANSFUSIONS AND IMMUNOSUPPRESSIVE TREATMENT.
36. EFFECT OF PRIOR THIRD-PARTY BLOOD TRANSFUSIONS ON CANINE RENAL ALLOGRAFT SURVIVAL.
37. THE INFLUENCE OF DL-A HISTOCOMPATIBILITY ON THE FUNCTION AND PATHOHISTOLOGICAL CHANGES IN UNMODIFIED CANINE RENAL ALLOGRAFTS.
38. POLYMORPHISM OF THE DL-A SYSTEM.
39. THE PRODUCTION AND EVALUATION OF DOG ALLOLYMPHOCYTOTOXINS FOR DONOR SELECTION IN TRANSPLANTATION EXPERIMENTS.
40. A COMPARATIVE STUDY OF HETEROLOGOUS ANTI-MOUSE LYMPHOCYTE AND ANTIMOUSE THYMO-CYTE SERA PREPARED BY TWO DIFFERENT IMMUNIZATION METHODS.
41. Joint Report of 1st International Workshop on Canine Immunogenetics.
42. Intralesional radiolabeled human monoclonal IgM in human tumor xenografts
43. Proposal for translational analysis and development of clinical radiolabeled immunoglobulin therapy
44. ENGRAFTMENT OF STEMCELLENRICHED BONE MARROW FRACTIONS IN MHCIDENTICAL DOGS AFTER FRACTIONATED TOTALBODY IRRADIATION1
45. GENETICS OF KIDNEY ALLOGRAFT SURVIVAL IN DOGS II RELEVANCE OF MINOR HISTOCOMPATIBILITY SYSTEMS IN RECIPIENTS WITHOUT IMMUNOSUPPRESSIVE THERAPY1
46. PROLONGATION OF RENAL ALLOGRAFT SURVIVAL IN DLA TISSUETYPED BEAGLES AFTER THIRDPARTY BLOOD TRANSFUSIONS AND IMMUNOSUPPRESSIVE TREATMENT
47. EFFECT OF PRIOR THIRDPARTY BLOOD TRANSFUSIONS ON CANINE RENAL ALLOGRAFT SURVIVAL
48. THE EFFECT OF DONOR BLOOD ON RENAL ALLOGRAFT SURVIVAL IN DLA TISSUE TYPED BEAGLE LITTERMATES
49. GENETIC ASPECTS OF CANINE MIXED LEUKOCYTE CULTURES
50. POLYMORPHISM OF THE DLA SYSTEM
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.